Skip to main content
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
5.25
+0.28 (5.63%)
Mar 9, 2026, 3:48 PM EDT - Market open

Perspective Therapeutics Revenue

Perspective Therapeutics had revenue of $209.00K in the quarter ending September 30, 2025, a decrease of -43.36%. This brings the company's revenue in the last twelve months to $1.08M, down -30.96% year-over-year. In the year 2024, Perspective Therapeutics had annual revenue of $1.45M with 1.39% growth.

Revenue (ttm)
$1.08M
Revenue Growth
-30.96%
P/S Ratio
536.19
Revenue / Employee
$7,679
Employees
140
Market Cap
598.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.45M20.00K1.39%
Dec 31, 20231.43M-3.98M-73.52%
Dec 31, 20225.42M--
Jun 30, 2022---
Jun 30, 202110.05M373.00K3.85%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Avanos Medical 701.20M
Bioventus 568.09M
Tactile Systems Technology 329.52M
Cytek Biosciences 201.49M
SI-BONE 200.93M
Beta Bionics 100.25M
Revenue Rankings

CATX News

More News